Clinical Trial Update: Clinical Trial to Assess the Importance of Nephrectomy [Phase 3]

View source ↗

Summary

A Phase 3 trial update evaluating the role of nephrectomy in metastatic renal cell carcinoma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Metastatic Renal Cell Carcinoma | Phase 3 | Status: COMPLETED